Your email has been successfully added to our mailing list.

×
-0.000477213075638347 -0.00226676210928177 -0.0023860653781914 -0.00167024576473396 -0.00226676210928177 0.00870913863039835 0.00942495824385579 0.0145549988069673
Stock impact report

Leading Medtech Stock Dives After Preliminary Sales Report Disappoints [Investor's Business Daily]

Boston Scientific Corp (BSX)  More Company Research Source: Investors Business Daily
Last boston scientific corp earnings: 4/29 06:30 am Check Earnings Report
US:NYSE Investor Relations: investors.bostonscientific.com
PDF Boston Scientific preliminarily announced disappointing fourth-quarter sales on Tuesday, sending BSX stock into a tailspin. The biggest shortfall came from cardiac rhythm management. The post Leading Medtech Stock Dives After Preliminary Sales Report Disappoints appeared first on Investor's Business Daily . [Read more]
Impact snapshot Event time: BSX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
BSX alerts

from News Quantified
Opt-in for
BSX alerts

from News Quantified